• Olsalazine Sodium: Applied Workflows in Cancer and Inflammat

  2026-05-25

  Olsalazine Sodium, a potent mesalamine dimer, accelerates anti-inflammatory and tumor apoptosis research thanks to its unique solubility and validated biological activity. Learn how recent experimental insights and protocol optimization strategies can transform colorectal cancer and vector biology investigations.

• Guanabenz Acetate: Precision α2-Adrenergic Receptor Agonist

  2026-05-25

  Guanabenz Acetate enables reproducible modulation of α2-adrenergic receptor pathways, empowering researchers to dissect GPCR signaling and stress response mechanisms with subtype-selective precision. Learn how to maximize assay reliability, troubleshoot solubility and stability, and leverage recent advances in immune pathway interrogation.

• Z-VDVAD-FMK: Precision Caspase-2 Inhibition in Apoptosis Ass

  2026-05-24

  Z-VDVAD-FMK empowers apoptosis research by providing robust, selective caspase-2 inhibition and clear mechanistic dissection of mitochondrial cell death pathways. Its reliable solubility, cross-caspase coverage, and protocol flexibility set it apart for translational and cancer research applications.

• Aclacinomycin A Workflows: Precision DNA Damage & Apoptosis

  2026-05-23

  Aclacinomycin A (Aclarubicin) empowers researchers with dual topoisomerase inhibition for high-fidelity modeling of DNA damage and apoptosis. By leveraging validated protocols and troubleshooting strategies, labs can achieve reproducible, mechanistically insightful results in cancer cell systems.

• Mechanisms of Spiroplasma eriocheiris Entry via Endocytosis

  2026-05-22

  Wei et al. reveal that Spiroplasma eriocheiris invades Drosophila Schneider 2 cells primarily through clathrin-mediated endocytosis and macropinocytosis, not caveolae-dependent pathways. Their experimental model clarifies host-pathogen interactions and provides a robust framework for dissecting endocytic mechanisms in invertebrate infection biology.

• L1023 Anti-Cancer Compound Library: Optimizing High-Throughp

  2026-05-22

  The L1023 Anti-Cancer Compound Library empowers cancer researchers to rapidly interrogate oncogenic signaling and accelerate biomarker-driven drug discovery. With pre-dissolved, pathway-specific agents and robust validation, L1023 streamlines high-throughput screening and maximizes reproducibility for even the most challenging oncology targets.

• 10058-F4 C-Myc-Max Dimerization Inhibitor: Evidence-Driven L

  2026-05-21

  This article guides biomedical researchers through common experimental challenges in cell viability and apoptosis assays, illustrating how the 10058-F4 C-Myc-Max dimerization inhibitor (SKU A1169) delivers reliable, reproducible results. Drawing on recent literature and validated protocols, we address workflow optimization and product selection, ensuring robust outcomes for acute myeloid leukemia and prostate cancer models.

• Optimizing Ceftolozane Dosing for P. aeruginosa Bacteremia

  2026-05-21

  This article discusses the innovative pharmacokinetic/pharmacodynamic (PK/PD) modeling approach used to refine ceftolozane/tazobactam dosing in patients with Pseudomonas aeruginosa bacteremia. The findings help inform precise dosing strategies, especially in patients with high renal clearance and variable MIC distributions, enhancing efficacy against resistant strains.

• Elevating Immunodetection: Next-Gen HRP Goat Anti-Mouse IgG

  2026-05-20

  Explore how APExBIO’s HRP Goat Anti-Mouse IgG (H+L) Antibody empowers translational researchers to dissect complex disease mechanisms, such as mitochondrial calcium dysregulation in diabetic cardiomyopathy, through robust, sensitive immunodetection in Western blot, ELISA, IHC, and ICC. Learn about mechanistic insights, competitive benchmarks, and actionable protocol guidance for pushing immunoassay sensitivity and reliability beyond current standards.

• LHb-RMTg Circuit Modulates Inflammatory Pain via Chemogeneti

  2026-05-20

  Sun et al. reveal that the lateral habenula (LHb) to rostromedial tegmental nucleus (RMTg) pathway directly modulates heat sensitivity in inflammatory pain, using chemogenetic and optogenetic techniques. Their findings clarify the circuit-level mechanism of pain regulation and highlight the utility of targeted neuronal modulation in pain research.

• Clozapine N-oxide (CNO): Precision Chemogenetics in Neurosci

  2026-05-19

  Clozapine N-oxide (CNO) is a biologically inert metabolite of clozapine, widely adopted as a chemogenetic actuator in neuroscience research. Its high specificity for engineered muscarinic DREADDs enables targeted neuronal activity modulation without off-target pharmacology. This dossier details mechanism, application, and workflow guidance, referencing APExBIO’s high-purity A3317 product.

• Pazopanib (GW-786034): Protocols and Innovation in Cancer Re

  2026-05-19

  Pazopanib (GW-786034) stands out as a multi-pathway inhibitor enabling targeted angiogenesis and tumor suppression, especially in genetically defined cancer models. Discover protocol refinements and troubleshooting insights to maximize its impact in advanced cancer biology workflows.

• Clozapine N-oxide (CNO): Reliable Chemogenetics in the Lab

  2026-05-18

  This article addresses real-world challenges in chemogenetic assays, focusing on Clozapine N-oxide (CNO, SKU A3317) as a solution for reproducible neuronal modulation. It delivers scenario-driven insights for biomedical researchers, emphasizing validated protocols, assay optimization, and vendor reliability to maximize data integrity in neuroscience workflows.

• Lysoptosis: Conserved Cell Death Pathway Regulated by Intrac

  2026-05-18

  This study establishes lysoptosis as a distinct, evolutionarily conserved lysosome-dependent cell death pathway, characterized by lysosomal membrane permeabilization and cathepsin release, and controlled by intracellular serpins. The findings clarify the molecular specificity of lysoptosis in contrast to other regulated cell death modalities, informing future apoptosis and cell death research in both cancer and non-cancer models.

• Olsalazine Sodium: Applied Workflows in Cancer & Inflammatio

  2026-05-17

  Olsalazine Sodium, a mesalamine dimer, excels as a potent tool for inflammation and colorectal cancer research with proven efficacy in tumor apoptosis and LTB4 chemotaxis inhibition. This article breaks down advanced experimental workflows, actionable troubleshooting, and the latest cross-domain applications, all anchored in quantitative data.

681 records 11/46 page Previous Next First page 上5页 1112131415 下5页 Last page